Member Info for HotblackDesiato

Hi Silver - I wonder how many of the posters who wanted Parker's head on a spike filled up with cheap shares and are now secretly quite grateful for the RF shotfest (typo?) as they are now printing money.

Amazing what more than doubling your cash in 10 days can do for the spirits.

Onwards!

Hi Stick - Revel or Airfix?

(Sorry, couldn't resist)

Hi Bailiff - as long as she didn't get any of your SAR shares then all is well. By any chance is Auckland the furthest point on the globe from Bailiff HQ?

Best wishes.

Quick Bailiff, get Mrs. Bailiff on another cruise!

Evening all - I just hope that the success of the recent WRAP offer (hats off to B-B et al) will open the BoD's eyes and any future fundraise will be available through all major platforms. I'm still miffed that Halifax didn't take part even though I managed to fill my ISA for this year at sub-12p - no pleasing some folk!

Just thinking aloud so apologies if I'm way off the mark -

If the BoD received a glowing report from P1a tomorrow would it be in their interest to delay the news until they'd got shot of RF as much as possible? I know significant news needs to be RNS'd immediately but they could sit on it for a wee while yet under the guise of giving the report full consideration and planning next steps etc. In the meantime RF dump their shares reducing what they are due (excluding warrants). The BoD could then announce the results, ensuring the sp has a chance of a clear run much higher without extended RF sells to hold it back.

Stellar results and a positive Investor Meets presentation telling us all how wonderful 1801 is might go some way to gloss over the RF debacle. Yes, there are still unanswered questions over RF & PH but seeing JR doing cartwheels over his invention would quickly take the sting out of recent events.

Is it fair to presume any recent shorts are now closed? There are a few short trackers on the web but I don't see any evidence PH had a short unless it was below the threshold for declaring it.

https://www.fca.org.uk/markets/short-selling/notification-disclosure-net-short-positions

https://www.investegate.co.uk/company/SAR/short-positions

https://shorttracker.co.uk/company/GB00B02RFS12/

A steady daily climb of 10% will do nicely.

Hi Laz - I can almost imagine a sort of domino effect. RF needed funds to carry out their reverse takeover of SVEN but couldn't raise the cash so their only option was to dump chunks of their portfolio to prop themselves up. That led to the decimation of our sp and a great deal of finger pointing. If the city/AIM weren't in the state they're in then maybe both SAR & RF could've accessed the funding each needed without all the resulting fallout.

I expect we'll never know the real truth of the matter.

Interesting article, George. It echoes another post I put up the other day and gives some support to the notion that the city wasn't keen to help us raise funds thereby leading to the RF situation.

OFFS!! "further along the road than P1b"

Sorry, should read "...further along the road than P1a"

Evening Celtic - the SAD/MAD/Food trials are all about ensuring there are no nasty side effects based on varying dosage. So far the BoD has only been able to state, "... interim data shows that levels of SDC-1801 in blood are already in the expected therapeutic range, and achieve concentrations greater than those predicted to reduce signalling of cytokines dependent on TYK2 and/or JAK1 activity by 50% for a sustained period following once daily oral dosing. Safety data remains blinded, but no serious adverse events have been reported to date."

So far, so good.

It's only once they complete the MAD trial and get the safety data that they can start testing 1801 in psoriasis patients. That would be the P1b part of the trial however the BoD have said they are looking to skip 1b and head for Phase 2a (broadly speaking they serve the same purpose and would have the same number of patients). The bonus for us is it accelerates things in the sense that P2a is further along the road than P1a and so a successful P2a would result in 1801 having a much higher monetary value compared to completing a P1b.

As far as I can tell the final volunteers for P1a were recruited at the start of Jan and I think we're looking at 2mths from them starting the trial (screening etc.) and the follow-up (any side effects?). That suggests we're maybe now into the window where the safety review committee are looking at the data and deciding if the P2a trial can go ahead and what dose should be used.

The trial will have created a huge amount of data and isn't something that can be skimmed through to arrive at a judgement. No idea how long it'll take to get a verdict but we must be talking a matter of only a few weeks.

Why on earth would the BoD buy on the open market when they could put the money directly into the business where it can contribute to progressing 1801/2?

Google Finance showing up 17% and near enough 15p a share.

And by the same token Potnak, you'd think the third parties they employ would include a degree of slippage in what timeframe they give to our BoD.

Time for a very long walk through the woods.

Regards.

Only up to a point, Potnak. As they outsource a great deal of work the BoD are at the mercy of others' own delays.

Hi Laz, as we aren't privy to all the meetings and therefore all the facts we are left to consider all the what ifs.

Further to the quote I posted yesterday from RF's RNS, is it possible that our current sp is down to nothing more than bad timing? The quote was from RGO's 22/3/24 RNS:

"...in advance of the Proposed Acquisition, the Company's existing debt and equity-linked portfolio investment portfolio has been redeemed in order to provide additional cash funds for RGO going forward whilst, at this stage, RGO's other investments, including the new loan to SVEN will be retained."

Is it simply a case of, if RF weren't focused on gathering funds to do a reverse takeover then they wouldn't have needed to dump our shares in order to accumulate whatever money was needed? If RF weren't looking to do the reverse t/o then perhaps they'd have had no need to sell their SAR shares.

If the above is correct then it might simply be that RF intended holding onto our shares for a big pay-off but they just didn't have enough funds to allow them to do that. The net result is they had no option but to sell our shares though safe in the knowledge they'd be issued more.

More over-thinking of the situation is available upon request.

Sorry, too early for mental arithmatic, now have five times as many shares. Woohoo.

I agree, Silver. My average is now a third of what it was two weeks ago and I've now got four times as many shares. My target sp is now greatly reduced and I believe quite achievable.

I vaguely recall Tim suggesting 1801 & 1802 could be worth £800m each. I don't think we'll reach those dizzying heights but looking at other deals, the values don't seem crazy. Plus we all know a license or sale would be based on the potential value of the compound, not the current m/cap of the company.

From RGO's 22/3/24 RNS, "...In advance of the Proposed Acquisition, the Company's existing debt and equity-linked portfolio investment portfolio has been redeemed in order to provide additional cash funds for RGO going forward whilst, at this stage, RGO's other investments, including the new loan to SVEN will be retained."

Maybe RGO now plan to actually hold on to the shares they'll get on Friday. And in other news, pigs might fly.